As further evidence that components of the GSK3β/MITF axis are affected by Rab7a/TPC2 activity, we demonstrated that β-Catenin is reduced in Rab7a as well as in TPC2 KO melanoma lines. This evidence concerns the gene TPCN2 and melanoma.